Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genotype/phenotype correlations in Wilms' tumor

V Huff1

  • 1Department of Experimental Pediatrics/Genetics, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

Medical and Pediatric Oncology
|November 1, 1996
PubMed
Summary

Investigating Wilms' tumor (WT) gene (WT1) mutations reveals genotype/phenotype correlations. Specific WT1 mutation types are linked to distinct WT patient groups, influencing disease presentation and etiology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Absence of PPP2R1A mutations in Wilms tumor.

Oncogene·2001
Same author

Pulmonary dysplasia, Denys-Drash syndrome and Wilms tumor 1 gene mutation in twins.

Pediatric nephrology (Berlin, Germany)·2001
Same author

Frequent association of beta-catenin and WT1 mutations in Wilms tumors.

Cancer research·2000
Same author

Familial Wilms' tumor with neural elements: characterization by histology, immunohistochemistry, and genetic analysis.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2000
Same author

Mutation in the PAX6 gene in twenty patients with aniridia.

Human mutation·2000

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • The Wilms' tumor (WT) gene, WT1, encodes a transcriptional regulator crucial for kidney development.
  • Understanding WT1 gene mutations is key to deciphering Wilms' tumor (WT) etiology and pathogenesis.
  • Genotype/phenotype correlations in WT patients offer insights into WT1 protein function and mutational mechanisms.

Purpose of the Study:

  • To investigate the relationship between WT1 gene mutations and clinical phenotypes in Wilms' tumor (WT) patients.
  • To identify specific mutational mechanisms and their role in the development of WT.
  • To explore functional differences between various types of WT1 mutations.

Main Methods:

  • Analysis of WT1 gene mutations across a cohort of WT patients.
  • Correlation of mutation types (deletion/insertion, missense, truncation) with clinical features (e.g., aniridia, genitourinary anomalies, bilateral disease).
  • Comparison of mutation patterns in WT patients with specific syndromes (e.g., Drash syndrome) versus those without.

Main Results:

  • Deletion/insertion mutations in WT1's first exon are linked to a deletion hotspot and may be enhanced by hemizygosity in WT/aniridia patients.
  • Germline WT1 mutations predominantly occur in patients with congenital genitourinary anomalies and/or bilateral disease, supporting a two-hit model.
  • Drash syndrome patients typically have germline missense WT1 mutations in zinc finger domains, while other WT/GU patients have truncating or deletion mutations.

Conclusions:

  • WT1 genotype/phenotype correlations provide critical insights into WT pathogenesis.
  • Distinct WT1 mutation types suggest functional differences, impacting WT development and presentation.
  • Understanding these correlations aids in predicting disease course and potentially developing targeted therapies for WT.

Related Experiment Videos